199 related articles for article (PubMed ID: 19385966)
21. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
Morishita K; Parganas E; Douglass EC; Ihle JN
Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
[TBL] [Abstract][Full Text] [Related]
22. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
Fuchs O
Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
[TBL] [Abstract][Full Text] [Related]
23. Localization of Evi-2 to chromosome 11: linkage to other proto-oncogene and growth factor loci using interspecific backcross mice.
Buchberg AM; Bedigian HG; Taylor BA; Brownell E; Ihle JN; Nagata S; Jenkins NA; Copeland NG
Oncogene Res; 1988; 2(2):149-65. PubMed ID: 2851124
[TBL] [Abstract][Full Text] [Related]
24. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.
Bobadilla D; Enriquez EL; Alvarez G; Gaytan P; Smith D; Slovak ML
Br J Haematol; 2007 Mar; 136(6):806-13. PubMed ID: 17341266
[TBL] [Abstract][Full Text] [Related]
25. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
[TBL] [Abstract][Full Text] [Related]
26. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.
Kustikova O; Fehse B; Modlich U; Yang M; Düllmann J; Kamino K; von Neuhoff N; Schlegelberger B; Li Z; Baum C
Science; 2005 May; 308(5725):1171-4. PubMed ID: 15905401
[TBL] [Abstract][Full Text] [Related]
27. [Pathogenetic significance of deregulated hematopoietic transcription factors in leukemia--Evi-1 as a critical regulator for hematopoiesis and leukemia].
Kurokawa M
Rinsho Ketsueki; 2009 Mar; 50(3):168-73. PubMed ID: 19352083
[No Abstract] [Full Text] [Related]
28. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene.
Bartholomew C; Morishita K; Askew D; Buchberg A; Jenkins NA; Copeland NG; Ihle JN
Oncogene; 1989 May; 4(5):529-34. PubMed ID: 2542863
[TBL] [Abstract][Full Text] [Related]
29. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal location of Evi-1, a common site of ecotropic viral integration in AKXD murine myeloid tumors.
Mucenski ML; Taylor BA; Copeland NG; Jenkins NA
Oncogene Res; 1988 Feb; 2(3):219-33. PubMed ID: 2897103
[TBL] [Abstract][Full Text] [Related]
31. [Leukemogenesis by the AML1/EVI-1 chimeric protein].
Mitani K; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):33-9. PubMed ID: 10643333
[No Abstract] [Full Text] [Related]
32. Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.
Nitta E; Izutsu K; Yamaguchi Y; Imai Y; Ogawa S; Chiba S; Kurokawa M; Hirai H
Oncogene; 2005 Sep; 24(40):6165-73. PubMed ID: 15897867
[TBL] [Abstract][Full Text] [Related]
33. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
34. The EVI-1 gene--its role in pathogenesis of human leukemias.
Jółkowska J; Witt M
Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
[TBL] [Abstract][Full Text] [Related]
35. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H
BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644
[TBL] [Abstract][Full Text] [Related]
36. The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas.
Koos B; Bender S; Witt H; Mertsch S; Felsberg J; Beschorner R; Korshunov A; Riesmeier B; Pfister S; Paulus W; Hasselblatt M
Clin Cancer Res; 2011 Jun; 17(11):3631-7. PubMed ID: 21493867
[TBL] [Abstract][Full Text] [Related]
37. Insertional mutagenesis and transformation of hematopoietic stem cells.
Ihle JN; Morishita K; Matsugi T; Bartholomew C
Prog Clin Biol Res; 1990; 352():329-37. PubMed ID: 2169632
[TBL] [Abstract][Full Text] [Related]
38. Evi-1 expression in Xenopus.
Mead PE; Parganas E; Ohtsuka S; Morishita K; Gamer L; Kuliyev E; Wright CV; Ihle JN
Gene Expr Patterns; 2005 Jun; 5(5):601-8. PubMed ID: 15905132
[TBL] [Abstract][Full Text] [Related]
39. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
[TBL] [Abstract][Full Text] [Related]
40. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
